[1]
C, V. et al. 2022. MI RISK ASSESSMENT IN PATIENTS USING THE EZ-CVD RISK ASSESSMENT TOOL. Asian Journal of Pharmaceutical and Clinical Research. 15, 9 (Sep. 2022), 123–125. DOI:https://doi.org/10.22159/ajpcr.2022.v15i9.45041.